Literature DB >> 6659871

Steroid receptors in meningiomas. A histochemical and biochemical study.

D Hinton, E G Mobbs, A A Sima, W Hanna.   

Abstract

Meningiomas are more common in females and their course can be affected by changes in the hormonal milieu of the patient. Recently, a few studies have reported the presence of one or more steroid receptors in a small number of meningiomas. We have studied the estrogen and progesterone receptors (ER and PgR) of 11 surgically excised meningiomas. The receptors were assayed biochemically and localized at the cellular level using fluoroceinated estradiol and rhodamine-conjugated progesterone. Considerable amounts of ER were found in 4/11 cases, and PgR was high in 6/11 tumors. Cytoplasmic localization of the steroid binding sites was seen using both tracers. The presence of 10% of cells with two ++ intensity of the fluorescence correlated with tumors having positive ER values (greater than 10 Fm/mg protein). The presence of nuclear fluorescence and the higher level of PgR seen in some tumors indicate that the ER present is functioning. This study confirms the presence of steroid binding sites in meningiomas and suggests that there may be a role for hormonal manipulation in selected patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6659871     DOI: 10.1007/BF00684930

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  30 in total

1.  The relapsing course of certain meningiomas in relation to pregnancy and menstruation.

Authors:  E R BICKERSTAFF; J M SMALL; I A GUEST
Journal:  J Neurol Neurosurg Psychiatry       Date:  1958-05       Impact factor: 10.154

2.  Estrogen receptor protein of pancreas.

Authors:  A A Sandberg; R Y Kirdani; M J Varkarakis; G P Murphy
Journal:  Steroids       Date:  1973-08       Impact factor: 2.668

3.  Specific binding of oestradiol in human uterine tissue.

Authors:  G Trams; B Engel; F Lehmann; H Maass
Journal:  Acta Endocrinol (Copenh)       Date:  1973-02

4.  The prognostic value of estrogen receptor determinations in patients with primary breast cancer: an update.

Authors:  P Furmanski; D E Saunders; S C Brooks; M A Rich
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

5.  Presence of steroid receptors in human soft tissue sarcomas of diverse histological origin.

Authors:  P K Chaudhuri; M J Walker; C W Beattie; T K Das Gupta
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

6.  Cellular estrogen and progesterone receptors in mammary carcinoma.

Authors:  S H Lee
Journal:  Am J Clin Pathol       Date:  1980-03       Impact factor: 2.493

7.  Estrogen-receptor protein in intracranial meningiomas.

Authors:  M S Donnell; G A Meyer; W L Donegan
Journal:  J Neurosurg       Date:  1979-04       Impact factor: 5.115

Review 8.  The use of steroïd hormone receptors in the treatment of human breast cancer: a review.

Authors:  C K Osborne; W L McGuire
Journal:  Bull Cancer       Date:  1979       Impact factor: 1.276

9.  Colonic neoplasms: tissue estrogen receptor and carcinoembryonic antigen.

Authors:  J E McClendon; D Appleby; D B Claudon; W L Donegan; J J DeCosse
Journal:  Arch Surg       Date:  1977-03

10.  Relationship between oestrogen-receptor content and histological grade in human primary breast tumours.

Authors:  P V Maynard; C J Davies; R W Blamey; C W Elston; J Johnson; K Griffiths
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

View more
  5 in total

1.  Osteoblastic meningiomas: clinico-pathological and immunohistochemical features of an uncommon variant.

Authors:  V Barresi; M Caffo; A Ieni; C Alafaci; G Tuccari
Journal:  J Neurooncol       Date:  2011-04-22       Impact factor: 4.130

2.  Hormonal modulation of brain tumour growth: a cell culture study.

Authors:  N Gibelli; C Zibera; G Butti; R Assietti; G Sica; M Scerrati; F Iacopino; R Roselli; P Paoletti; G Robustelli della Cuna
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

3.  Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases.

Authors:  J Jääskeläinen; E Laasonen; J Kärkkäinen; M Haltia; H Troupp
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

4.  Cryostat section assay of oestrogen and progesterone receptors in meningiomas: a clinicopathological study.

Authors:  J W Ironside; R D Battersby; V J Dangerfield; M A Parsons; W R Timperley; J C Underwood
Journal:  J Clin Pathol       Date:  1986-01       Impact factor: 3.411

5.  Sex steroid receptors in human meningiomas.

Authors:  G Blaauw; M A Blankenstein; S W Lamberts
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.